67 results
Page 2 of 4
8-K
EX-99.1
81b1rd7j56tsucqbom4t
16 Jun 22
Other Events
7:00am
8-K
EX-99.1
665zbxzhs9qt
9 May 22
Sutro Biopharma Reports First Quarter 2022 Financial Results, Business Highlights, and Anticipated Milestones
4:31pm
8-K
EX-99.1
pf05l9
28 Feb 22
Sutro Biopharma Reports Full Year 2021 Financial Results, Business Highlights, and Anticipated 2022 Milestones
4:36pm
8-K
EX-99.1
567e6kjgq1 u1n9hs3
10 Jan 22
Regulation FD Disclosure
7:01am
8-K
EX-99.2
4esi4xf3ul7vajq54r
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
kw538bkx9xkqq xbz
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
lnbdha
5 Jan 22
Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer
5:27pm
8-K
EX-99.1
fdmrr3stzvf6ep a6u7
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
EX-99.2
2u91xmw
10 Nov 21
Sutro Biopharma Reports Third Quarter 2021 Financial Results, Business Highlights, and Anticipated 2021 Milestones
7:03am
8-K
szgp26 zqr
30 Sep 21
Other Events
7:00am
8-K
EX-99.1
fwumpe6 e7
9 Aug 21
Business Highlights and Anticipated Second Half 2021 Milestones
7:01am
8-K
EX-99.2
s9ags62
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
rdrptw6gof194ehhpuzl
19 May 21
Regulation FD Disclosure
5:00pm
8-K
EX-99.1
toka4lrs
7 May 21
Business Highlights and 2021 Anticipated Milestones
7:00am